While I see your point, I still wonder who at CYDY was
While I see your point, I still wonder who at CYDY was responsible for telling Accounts Payable "Yep, all good, pay it all in full" for so long.
As you said, "Years and years of collecting payments, for what?" Didn't ANYONE look at anything that Amarex was allegedly doing? ANYONE?!?
I still don't get why no one here seems to want to hold CYDY accountable for anything, EVEN if Amarex was completely ineffective. To quote the classic film, Cool Hand Luke, "What we have here is a failure to communicate."
2
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
DeFi Must Step Up To Meet Compliance Challenge Alright, folks, here's the scoop: DeFi Technologies just picked up another 180 days from Nasdaq to get its act together and hit that crucial one-buck minimum bid price. It's like getting extra time on a pop quiz you forgot to study for—useful, but no guarantee they'll pass. What Led to the Extra Time? These guys over at...
Continue Reading
Surge in Revenue Growth Marks a Milestone for NOVOSENSE Give a pat on the back to NOVOSENSE (HKEX: 02676), because reporting a robust 66.73% bump in first-half revenue isn't small potatoes in today's tech landscape. This translates to around $374.54 million rolling into their coffers, which is quite a spectacle if you're watching the trend of sequential revenue growth...
Continue Reading
Changing the Game in Power Generation In the ever-shifting landscape of power generation, having a seasoned player at the helm can be the difference between stagnation and growth. FirstEnergy Corp. (NYSE:FE) has tapped Jon Dormo as its Vice President of Generation Project Development. The mission? Overhaul and expand projects to meet the increasing demands for...
Continue Reading
A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...
Continue Reading
A Bold Leap by TECNO You walk into the IFA ShowStoppers 2026 event, and what’s greeting you is a flashy splash of next-gen tech from TECNO. Now, if you thought this brand was only about pushing phones, you're in for a ride. TECNO has crashed the laptop party with its new MEGABOOK T15 360 Series, showing it’s more than capable of straddling the tablet and laptop worlds...
Continue Reading
Russo's Big Bet on Women-led Ventures There's nothing quite like a political shake-up promising to dig into government pockets without slamming taxpayers. Frank Russo, tossing his hat for Florida's governorship, is betting big on women entrepreneurs with a bold move—a $100 million Women’s Entrepreneurship Initiative. No new taxes, he claims, just smart financial...
Continue Reading
Navigating the Check Printing Landscape Let's dive right into the changing realities of the workspace. With remote work becoming the new standard, small businesses are juggling tighter budgets while trying to maintain smooth financial operations. It's a hard game, but here is where Halfpricesoft.com rolls out their newly upgraded multi-user ezCheckPrinting software,...
Continue Reading
Maxwell Joins VT Markets Amid Strategic Shift Forget the usual humdrum of C-suite comings and goings; this one's packed with punch. VT Markets is setting the stage for a serious leap forward by naming Ross Maxwell their new Chief Strategy Officer. This isn't just another desk job—it's a pivotal role meant to integrate cutting-edge technology with the ever-evolving...
Continue Reading
Redefining Aesthetic Surgery: An Artistic Approach The world of plastic surgery is often seen through the lens of beauty and symmetry, but for Dr. Emmanuel De La Cruz, it's like staring into a whole different universe. This Houston-based plastic surgeon isn't just removing fat—he's reshaping the human canvas with the eye of a sculptor. Beyond the Standard Cut and Snip...
Continue Reading
Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Current Landscape of Risk Management in Banking In recent findings from the Wolters Kluwer Regulatory & Risk Management Indicator survey, there's a notable shift in the concerns of the U.S. banking industry. Approximately half of the respondents reported elevated levels of concern regarding risk management and regulatory compliance efforts. Survey...
Continue Reading
Financial Performance Overview The Wendy's Company (NASDAQ: WEN) has recently shared its performance results for the third quarter, revealing some intriguing dynamics within its financial metrics. Global systemwide sales reached $3.5 billion, reflecting a notable decrease of 2.6%. This decline can largely be attributed to lower same-restaurant sales in the U.S., which...
Continue Reading
ALLIANCE TRUST PLC As of the end of business on a recent Wednesday, Alliance Trust PLC has shared its updated Net Asset Value (NAV) per ordinary share, providing valuable insights into its financial standing. Now, what’s the deal with NAV? It’s not just some dry number—it’s essentially a pulse check on how the company is doing financially. In this context, it...
Continue Reading
DeltaPrime's Reimbursement Strategy Explained DeltaPrime, a frontrunning DeFi prime brokerage, is taking significant steps to support its users after a recent security breach led to substantial financial loss. The breach, which occurred on September 16, resulted in a loss of approximately $5.98 million on their Deltaprime Blue protocol. In a demonstration of commitment to...
Continue Reading
Understanding the Nuclear Sector's Current Landscape As we analyze the nuclear sector's performance towards the end of the year, it's evident that investors in advanced nuclear technology might feel uneasy. Recent declines in stock prices have raised concerns among shareholders. For instance, Oklo has faced a substantial fall of 36% in the last quarter alone. Similarly,...
Continue Reading